Greg Yanik
University of Michigan(US)University of Michigan–Ann Arbor(US)Michigan Medicine(US)Clinical Research Consortium(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Cancer Treatment and Pharmacology, Hematopoietic Stem Cell Transplantation, Cancer therapeutics and mechanisms
Most-Cited Works
- → Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.(1996)161 cited
- → National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report(2021)159 cited
- → Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes(2012)112 cited
- → Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma(2018)87 cited
- → Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial(2012)73 cited